Foghorn Therapeutics Future Growth
Future criteria checks 2/6
Foghorn Therapeutics is forecast to grow earnings and revenue by 6.2% and 44.2% per annum respectively while EPS is expected to grow by 21.9% per annum.
Key information
6.2%
Earnings growth rate
21.9%
EPS growth rate
| Biotechs earnings growth | 21.1% |
| Revenue growth rate | 44.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Companies Like Foghorn Therapeutics (NASDAQ:FHTX) Are In A Position To Invest In Growth
Apr 12
Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Share Price Boosted 71% But Its Business Prospects Need A Lift Too
Feb 22Foghorn Therapeutics Inc. (NASDAQ:FHTX) Shares Fly 33% But Investors Aren't Buying For Growth
Dec 13Need To Know: Analysts Are Much More Bullish On Foghorn Therapeutics Inc. (NASDAQ:FHTX) Revenues
Nov 07Foghorn Therapeutics (NASDAQ:FHTX) Is In A Good Position To Deliver On Growth Plans
Jun 14Foghorn Therapeutics: Selling For Less Than Cash Value
Oct 10Foghorn stock slumps 18% as FDA places full clinical hold on blood cancer trial of FHD-286
Aug 23Foghorn Therapeutics GAAP EPS of -$0.66 misses by $0.07, revenue of $4.49M
Aug 09Foghorn: Big Pharma Interest, Resolvable Clinical Hold Equals Opportunity
Jun 02We're Hopeful That Foghorn Therapeutics (NASDAQ:FHTX) Will Use Its Cash Wisely
Apr 13Are Insiders Buying Foghorn Therapeutics Inc. (NASDAQ:FHTX) Stock?
Feb 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 63 | -237 | -105 | N/A | 3 |
| 12/31/2025 | 37 | -221 | -116 | N/A | 5 |
| 12/31/2024 | 35 | -247 | -104 | -26 | 4 |
| 12/31/2023 | 34 | -98 | -119 | -118 | N/A |
| 9/30/2023 | 33 | -103 | -121 | -119 | N/A |
| 6/30/2023 | 22 | -115 | -114 | -112 | N/A |
| 3/31/2023 | 21 | -112 | -111 | -109 | N/A |
| 12/31/2022 | 19 | -109 | 192 | 194 | N/A |
| 9/30/2022 | 16 | -109 | 233 | 234 | N/A |
| 6/30/2022 | 9 | -109 | 233 | 234 | N/A |
| 3/31/2022 | 5 | -105 | 243 | 244 | N/A |
| 12/31/2021 | 1 | -101 | -54 | -50 | N/A |
| 9/30/2021 | 1 | -93 | -84 | -73 | N/A |
| 6/30/2021 | 1 | -85 | -65 | -50 | N/A |
| 3/31/2021 | 1 | -78 | -61 | -44 | N/A |
| 12/31/2020 | 0 | -69 | -47 | -31 | N/A |
| 9/30/2020 | 0 | -63 | -43 | -34 | N/A |
| 6/30/2020 | N/A | -58 | -52 | -49 | N/A |
| 3/31/2020 | N/A | -54 | -48 | -47 | N/A |
| 12/31/2019 | N/A | -51 | -47 | -46 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FHTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FHTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FHTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: FHTX's revenue (44.2% per year) is forecast to grow faster than the US market (7.9% per year).
High Growth Revenue: FHTX's revenue (44.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FHTX's Return on Equity is forecast to be high in 3 years time